...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Published 8 days ago; review article out of Qatar Univ.

Yep , yet another article & id say a very good one at that but with the same ending , more trials needed , more research needed  etc etc etc. & again we didn't hear or get this from RVX , prob to excited & busy to get this out in a more timely manner. Like I've said before if we had a penny for every paper we would be over Buck!

& at 6-7 Pennie's where's all the money & plan for the vast amount of research still needed??

 

"Given that the drug is novel and is still in clinical trials, further preclinical research and clinical trials are warranted to fully explore the therapeutic potential of apabetalone in a wide range of oncological and non-oncological disease contexts."
Share
New Message
Please login to post a reply